XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating Activities    
Net loss $ (8,120) $ (701)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation, amortization and accretion 2,230 2,301
Stock-based compensation expense 930 1,177
Loss (gain) on derivative warrant liabilities 5,907 (2,191)
Amortization of senior debt discount 148 145
Loss from contingent consideration   155
Inventory write-down 51 82
Other noncash adjustments (6) (33)
Changes in operating assets and liabilities:    
Accounts receivable (945) (6,212)
Inventories (1,023) (2,104)
Prepaid expenses and other current assets 1,125 (1,801)
Accounts payable and other 914 3,587
Accrued liabilities (5,166) (3,481)
Other operating assets and liabilities, net 3,744 (72)
Net cash used in operating activities (211) (9,148)
Investing Activities    
Other investing activities (76) 42
Net cash (used in) provided by investing activities (76) 42
Financing Activities    
Proceeds from issuance of stock and warrants   10,416
Net (payments made on) proceeds received from, short-term line of credit (348) 4,274
Payment made to fixed payment arrangement (2,204) (301)
Payment of stock issuance costs (160) (793)
Payments made to borrowings (22) (26)
Other financing activities   (13)
Net cash (used in) provided by financing activities (2,734) 13,557
Net change in cash and cash equivalents (3,021) 4,451
Cash and cash equivalents at beginning of period 22,985 19,360
Cash and cash equivalents at end of period 19,964 23,811
Supplemental cash flow data    
Cash paid for interest $ 1,359 565
Non-cash investing and financing activities:    
Fair value of warrants at issuance, net   5,953
Other noncash investing and financing activities   $ 146